EMOCLOT

This brand name is authorized in Croatia, Ecuador, Malta, Poland, Romania, Tunisia, Turkey.

Active ingredients

The drug EMOCLOT contains one active pharmaceutical ingredient (API):

1	Coagulation factor VIII UNII 839MOZ74GK - ANTIHEMOPHILIC FACTOR HUMAN
	Activated factor VIII acts as a cofactor for activated factor IX, accelerating the conversion of factor X to activated factor X (factor Xa). Haemophilia A is a sex-linked hereditary disorder of blood coagulation due to decreased levels of factor VIII:C. By replacement therapy the plasma levels of factor VIII are increased, thereby enabling a temporary correction of the factor deficiency and correction of the bleeding tendencies.
	Read more about Coagulation factor VIII

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EMOCLOT Powder and solvent for solution for infusion	MPI, EU: SmPC	Medicines Authority (MT)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BD02	Coagulation factor VIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	65-MBE-0716, 66-MBE-0716
HR	Agencija za lijekove i medicinske proizvode	HR-H-037989490, HR-H-956160065
MT	Medicines Authority	MA128/00202
PL	Rejestru Produktów Leczniczych	100113184, 100113190
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W13336001
TN	Direction de la Pharmacie et du Médicament	13043031H
TR	İlaç ve Tıbbi Cihaz Kurumu	8680972009021, 8680972009038